Anatomical versus non-anatomical resection for hepatocellular carcinoma

British Journal of Surgery

Volumn 102, Issue 7, 2015, Pages 776-784

  Marubashi, S ^a   Gotoh, K ^a   Akita, H ^a   Takahashi, H ^a   Ito, Y ^a   Yano, M ^a   Ishikawa, O ^a   Sakon, M ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMY AND HISTOLOGY; CARCINOMA, HEPATOCELLULAR; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; JAPAN; LIVER; LIVER NEOPLASMS; LIVER RESECTION; MALE; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PROCEDURES; PROPENSITY SCORE; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TRENDS;

CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; JAPAN; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84929030000     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9815     Document Type: Article

References (43)

1. Bosch FX, Ribes J, Diaz M, Cleries R,. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127 (Suppl 1): S5-S16.
2. Tiong L, Maddern GJ,. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-1224.
3. Sakon M, Nagano H, Nakamori S, Dono K, Umeshita K, Murakami T, et al. Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg 2002; 137: 94-99.
4. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F,. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991; 214: 114-117.
5. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993; 105: 488-494.
6. Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC,. Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129: 738-742.
7. Duffy JP, Hiatt JR, Busuttil RW,. Surgical resection of hepatocellular carcinoma. Cancer J 2008; 14: 100-110.
8. Poon RT, Fan ST, Lo CM, Liu CL, Wong J,. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373-382.
9. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-691.
10. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'Eng FK,. Liver resection for hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2005; 92: 348-355.
11. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003; 237: 536-543.
12. Makuuchi M, Hasegawa H, Yamazaki S,. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985; 161: 346-350.
13. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, et al. Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999; 86: 1032-1038.
14. Yamamoto M, Takasaki K, Ohtsubo T, Katsuragawa H, Fukuda C, Katagiri S,. Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. Surgery 2001; 130: 443-448.
15. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005; 242: 252-259.
16. Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143: 469-475.
17. Sasaki K, Matsuda M, Ohkura Y, Hashimoto M, Watanabe G,. Anatomical versus nonanatomical resection in patients with hepatocellular carcinoma located in the left lateral segment. Am Surg 2013; 79: 1163-1170.
18. Ochiai T, Ikoma H, Yamamoto Y, Konishi H, Murayama Y, Shiozaki A, et al. Anatomical hepatectomy for hepatocellular carcinoma in patients with preserved liver function. Anticancer Res 2013; 33: 1689-1695.
19. Sakon M, Nagano H, Shimizu J, Kondo M, Nakamori S, Dono K, et al. Hepatic resection of hepatocellular carcinomas based on tumor hemodynamics. J Surg Oncol 2000; 73: 179-181.
20. Sakon M, Ogawa H, Fujita M, Nagano H,. Hepatic resection for hepatocellular carcinoma based on tumor hemodynamics. Hepatol Res 2013; 43: 155-164.
21. Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, et al. Anatomic resection independently improves long-term survival in patients with T1-T2 hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 1356-1365.
22. Ueno S, Kubo F, Sakoda M, Hiwatashi K, Tateno T, Mataki Y, et al. Efficacy of anatomic resection vs nonanatomic resection for small nodular hepatocellular carcinoma based on gross classification. J Hepatobiliary Pancreat Surg 2008; 15: 493-500.
23. Zhou Y, Xu D, Wu L, Li B,. Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg 2011; 396: 1109-1117.
24. Kaibori M, Matsui Y, Hijikawa T, Uchida Y, Kwon AH, Kamiyama Y,. Comparison of limited and anatomic hepatic resection for hepatocellular carcinoma with hepatitis C. Surgery 2006; 139: 385-394.
25. Tanaka K, Shimada H, Matsumoto C, Matsuo K, Nagano Y, Endo I, et al. Anatomic versus limited nonanatomic resection for solitary hepatocellular carcinoma. Surgery 2008; 143: 607-615.
26. Kang CM, Choi GH, Kim DH, Choi SB, Kim KS, Choi JS, et al. Revisiting the role of nonanatomic resection of small (< or = 4 cm) and single hepatocellular carcinoma in patients with well-preserved liver function. J Surg Res 2010; 160: 81-89.
27. Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, et al. Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function. Dig Dis Sci 2012; 57: 1942-1948.
28. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996; 276: 889-897.
29. D'Agostino RB Jr,. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
30. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS,. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA 2001; 286: 1187-1194.
31. Payen D, Gayat E,. Which general intensive care unit patients can benefit from placement of the pulmonary artery catheter? Crit Care 2006; 10 (Suppl 3): S7.
32. Austin PC,. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 2014; 33: 1242-1258.
33. Klein JP, Moeschberger ML,. Survival Analysis: Techniques for Censored and Truncated Data. Springer: NewYork, 1997.
34. The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan. Jpn J Surg 1989; 19: 98-129.
35. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer (2nd English edn). Kanehara: Tokyo, 2003.
36. Clinical Practice Guidelines for Hepatocellular Carcinoma-The Japan Society of Hepatology 2009 update. Hepatol Res 2010; 40 (Suppl 1): 2-144.
37. Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, et al. Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg 2014; 259: 336-345.
38. Austin PC,. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46: 399-424.
39. Yeh CN, Chen MF, Lee WC, Jeng LB,. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002; 81: 195-202.
40. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K,. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14: 802-805.
41. Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38: 200-207.
42. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009; 137: 850-855.
43. Sumie S, Nakashima O, Okuda K, Kuromatsu R, Kawaguchi A, Nakano M, et al. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma. Ann Surg Oncol 2014; 21: 1002-1009.